 |
|
|
| |
Resistance analysis of long-acting lenacapavir in highly
treatment-experienced people with HIV after 26 weeks of treatment
|
| |
| |
EACS 2021 Oct 27-30
N. Margot 1; L. VanderVeen1; V. Naik1; S. Chang1; P.C. Parvangada1; R. Martin1; H. Dvory-Sobol2; M. Rhee2; C. Callebaut1
1Gilead Sciences Inc., Clinical Virology, Foster City, United States; 2Gilead Sciences Inc., Clinical Research, Foster City, United States
|
| |
|
|
|
|
|
